Targeting autophagy in disease: established and new strategies

por Kocak, Muhammed, Ezazi Erdi, Saba, Jorba, Guillem, Maestro, Inés, Farrés, Judith, Kirkin, Vladimir, Martinez, Ana, Pless, Ole
Publicado 2021

In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan

por Jorba, Guillem, Aguirre-Plans, Joaquim, Junet, Valentin, Segú-Vergés, Cristina, Ruiz, José Luis, Pujol, Albert, Fernández-Fuentes, Narcís, Mas, José Manuel, Oliva, Baldo
Publicado 2020

Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach

por Carcereny, Enric, Fernández-Nistal, Alonso, López, Araceli, Montoto, Carmen, Naves, Andrea, Segú-Vergés, Cristina, Coma, Mireia, Jorba, Guillem, Oliva, Baldomero, Mas, Jose Manuel
Publicado 2021

Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate

por Gutiérrez-Casares, José Ramón, Quintero, Javier, Jorba, Guillem, Junet, Valentin, Martínez, Vicente, Pozo-Rubio, Tamara, Oliva, Baldomero, Daura, Xavier, Mas, José Manuel, Montoto, Carmen
Publicado 2021

A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis

por Coto-Segura, Pablo, Segú-Vergés, Cristina, Martorell, Antonio, Moreno-Ramírez, David, Jorba, Guillem, Junet, Valentin, Guerri, Filippo, Daura, Xavier, Oliva, Baldomero, Cara, Carlos, Suárez-Magdalena, Olaya, Abraham, Sonya, Mas, José Manuel
Publicado 2023